Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx
Christopher G Youn, Joo Yeon Kim, Vivian B Yang, Gordon H Bae, Robert Dellavalle · 2024
Read Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx by Christopher G Youn, Joo Yeon Kim, Vivian B Yang, Gordon H Bae, Robert Dellavalle (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11661688.txt.
Description
Christopher Youn and co-authors compare in 2024 skin drug prices at the Mark Cuban Cost Plus Drug Company against GoodRx prices. High drug costs burden many patients with skin disease. The cost analysis finds that Cost Plus pricing holds strong promise to cut what patients pay out of pocket for dermatology drugs.
Catalog record
| CREATOR | Christopher G Youn, Joo Yeon Kim, Vivian B Yang, Gordon H Bae, Robert Dellavalle |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 9 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |